Suchergebnisse - MRX-2843

1

Therapeutic Targeting of MERTK and BCL-2 in T-Cell and Early T-Precursor Acute Lymphoblastic Leukemia

von: Ryan J. Summers

2022, in: Cancers

Wird geladen...
2

Inhibition of Mcl-1 Synergistically Enhances the Antileukemic Activity of Gilteritinib and MRX-2843 in Preclinical Models of

von: Shuangshuang Wu

2022, in: Cells

Wird geladen...
3

Development of constitutively synergistic nanoformulations to enhance chemosensitivity in T-cell leukemia

von: Kelvin, James M.

2023, in: Journal of controlled release

Wird geladen...
4

MERTK activation drives osimertinib resistance in EGFR-mutant non–small cell lung cancer

von: Dan Yan

2022, in: The Journal of Clinical Investigation

Wird geladen...
5

Constitutively Synergistic Multiagent Drug Formulations Targeting MERTK, FLT3, and BCL-2 for Treatment of AML

von: Kelvin, James M.

2023, in: Pharmaceutical research

Wird geladen...
6

Securing integrity of high-temperature pressure boundary components in supercritical thermal plants with application of alternative design rules

von: Lee, Hyeong-Yeon

2022transfer abstract, in: Effect of APOE and family history of dementia on Alzheimer’s imaging biomarkers in cognitively normal individuals

Wird geladen...
7

Inhibiting efferocytosis reverses macrophage-mediated immunosuppression in the leukemia microenvironment

von: Joselyn Cruz Cruz

2023, in: Frontiers in Immunology

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!